WILTONLOGIC - Key Persons
Job Titles:
- Member of the Management Team
John Evenden has PhDs in Experimental Psychology from the University of Cambridge, England and Medical Pharmacology from the Uppsala University in Sweden. He did postdoctoral studies as a Research Fellow in the Psychobiology Laboratory at Harvard University and in the Department of Anatomy at the University of Cambridge. Although primarily studing the effects of drugs on the behaviour of animals, Dr Evenden also played an important role in the design and construction of the CANTAB neuropsychological test battery. In 1987 he moved to the pharmaceutical industry, working first at the MSD Neuroscience Research Center, and in 1989 moving to AB Astra, in Södertälje, Sweden. In 1999, Dr Evenden moved to the USA to assist in building up Astra's and then AstraZeneca's neuroscience research in the USA, where he served as Associate Director for Behavioural Pharmacology. Dr Evenden also acted as project leader for multidisciplinary drug discovery projects, as well as having a long involvement in early stage development projects in the areas of depression and cognition. In 2008 he left AstraZeneca and founded WiltonLogic, to apply his experience in translational neuroscience to developing new methods for studying impulsivity and decision making in humans and animals.
John Evenden has PhDs in Experimental Psychology from the University of Cambridge, England and Medical Pharmacology from the Uppsala University in Sweden. In 2008 he founded WiltonLogic, to apply his experience in translational neuroscience to developing new methods for studying impulsivity and decision making in humans and animals. Click on John's name for a full biography.
Job Titles:
- Member of the Management Team
Marja Mattila-Evenden qualified as a medical doctor at the University of Helsinki, Finland, where she also obtained a PhD in Pharmacology, studying the effects of drug on human psychomotor performance. In 1990, Dr Mattila-Evenden moved to the Karolinska Hospital, in Stockholm, Sweden for post-doctoral studies including detailed education on the use of clinical rating scales in psychiatry. There she completed here specialization in Psychiatry and obtained as position as Attending Doctor at the Magnus Huss Klinik. After moving to the USA, Dr Mattila-Evenden worked in clinical trials at Jefferson University Hospital in Philadelphia, before completing a residency in the Dept of Psychiatry and Behavioral Science at Temple University, and a fellowship in Addiction Psychiatry at the University of Pennsylvania. Dr Mattila-Evenden has long experience in the design and execution of research studies with healthy human subjects and psychiatric patients in academic studies and industry-sponsored trials. In 2008, she conducted the first field tests of procedures from the WiltonLogic test portfolio at Episcopal Hospital, Philadelphia, and has had a major role in the direction of WiltonLogic's strategy.
Marja Mattila-Evenden qualified as a medical doctor at the University of Helsinki, Finland, where she also obtained a PhD in Pharmacology, studying the effects of drug on human psychomotor performance. In 2008, she conducted the first field tests of procedures from the WiltonLogic test portfolio at Episcopal Hospital, Philadelphia, and has had a major role in the direction of WiltonLogic's strategy.
Yingbo Wang is currently majoring in computer engineering at the University of Delaware. She has been involved in the development of the software for the WiltonLogic test battery since June 2008.